Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;16(11):561-570.

Current Management of Alcohol-Associated Liver Disease

Affiliations

Current Management of Alcohol-Associated Liver Disease

Faisal A Siddiqi et al. Gastroenterol Hepatol (N Y). 2020 Nov.

Abstract

Alcohol consumption is a major risk factor for various diseases worldwide and is one of the most common causes of chronic liver disease. Alcohol use has risen over the past 30 years and is forecast to continue to rise. Concurrently, there has been an increased incidence of alcohol-associated liver disease (ALD). Alcohol use, regardless of the amount, leads to years of health loss across populations when considering the strong association between alcohol consumption and overall disease burden. Given the rising incidence of ALD and associated mortality, it is imperative to study the underlying factors driving these trends. This article summarizes the diagnosis and management of ALD, with a focus on various screening and prognostic tools and treatments for alcohol-associated hepatitis.

Keywords: Alcohol-associated liver disease; alcohol-associated hepatitis; alcoholic cirrhosis; alcoholic hepatitis; cirrhosis; liver transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant conflicts of interest to disclose.

Figures

Figure.
Figure.
Proposed algorithm for liver transplant evaluation in patients with alcohol-associated liver disease. PEth, phosphatidylethanol; SALT, Sustained Alcohol Use Post–Liver Transplant; THC, tetrahydrocannabinol. aSALT score adapted from Lee et al.52 A score of 5 or higher has a 95% negative predictive value of predicting alcohol use posttransplant.

References

    1. Rehm J, Shield KD. Global burden of alcohol use disorders and alcohol liver disease. Biomedicines. 2019;7(4):99. - PMC - PubMed
    1. Rehm J, Gmel GE, Sr, Gmel G et al. The relationship between different dimensions of alcohol use and the burden of disease–an update. Addiction. 2017;112(6):968–1001. - PMC - PubMed
    1. Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C, Rehm J. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393(10190):2493–2502. - PubMed
    1. Ventura-Cots M, Ballester-Ferré MP, Ravi S, Bataller R. Public health policies and alcohol-related liver disease. JHEP Rep. 2019;1(5):403–413. - PMC - PubMed
    1. Goldberg D, Ditah IC, Saeian K et al. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology. 2017;152(5):1090–1099.e1. - PMC - PubMed

LinkOut - more resources